ERC Advanced Grants Call

ERC Advanced Grants support excellent Principal Investigators with a recognized track record of research achievements. 

This call is open to researchers of any nationality to conduct their research activity in any ERC Member State or Associated Country.

The ERC's frontier research grants operate on a bottom-up basis, and have three separate research domains:

• Physical Sciences & Engineering
• Life Sciences 
• Social Sciences & Humanities

The budget for the three domains combined is 450,000,000 euros. 

The submission deadline is the 21st of October, 2014. For more details and relevant documents, visit the ERC call announcement. 

Please visit ORS or email Paul, Glad or Tim if you are interested in applying for these grants. 

NIH Grant: Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21), PAR-14-028

NIH has announced a request for application for collaborative projects looking at Mobile Health in Low and Middle Income Countries (LMIC).

The purpose of this Funding Opportunity is to encourage exploratory/developmental research applications that propose to study the development or adaptation of innovative mobile health (mHealth) technology specifically suited for LMICs and the health-related outcomes associated with implementation of the technology. Of highest interest are well-designed multidisciplinary projects that focus on tools or interventions for chronic diseases or technology for disease agnostic/cross-cutting applications.

Applicants are required to propose partnerships between at least one U.S. institution and one LMIC institution. The overall goal of the FOA is to contribute to the evidence base for the use of mobile technology to improve clinical outcomes and public health while building research capacity in LMICs and establishing research networks in this area.

Key info:

• Letter of Intent due date: January 19, 2015
• Application due date: February 19 2015
• Earliest project start date: September, 2015

• Award Budget: Applicants may request up to $125,000 direct costs per year.
• Total project period may not exceed 2 years

If you are interested, click here for the full RFA. If you are considering applying, please get in touch with Paul, Tim, or Glad at the Office of Rersearch Services.

International Research Ethics Education and Curriculum Development Award (R25) (PAR-13-027)

International Research Ethics Education and Curriculum Development Award (Bioethics )

Status: Open

Announcement(s)

• International Research Ethics Education and Curriculum Development Award (R25) (PAR-13-027)

Deadlines

• Upcoming letter of intent due dates: April 22, 2015
• Upcoming application due dates: May 22, 2015

Eligibility

• Applications from foreign organizations must be from institutions located in countries defined by The World Bank as low income, lower-middle income or upper-middle income. See The World Bank Country and Lending Groups to identify countries with low- or middle-income economies.
• Applicants are encouraged to collaborate with Fogarty Research and Research Training programs, or with other NIH grantees working in the developing countries where trainees are recruited. Collaboration with partners (listed below) is also encouraged.
• View full eligibility in the program announcement.

Award Project Period

The total project period for a new or renewal application submitted in response to this funding opportunity may not exceed 5 years.

Award Budget

New education program applications may request a budget of up to $230,000 [about 7,130,000 Baht] direct costs per year, or $1,150,000 (about 35.65 million Baht) over 5 years).

Indirect Costs

Indirect Costs (also known as Facilities & Administrative [F&A] Costs) are reimbursed at 8% of modified total direct costs (MTDC) (exclusive of tuition and fees and expenditures for equipment), rather than on the basis of a negotiated rate agreement.

The purpose of the International Research Ethics Education and Curriculum Development Award is to develop master's level curricula and provide educational opportunities for developing country academics, researchers and health professionals in ethics related to performing research involving human subjects in international resource poor settings. The goal of this initiative is to increase the number of developing country scientists, health professionals and relevant academics with in-depth knowledge of the ethical considerations, concepts and applications in clinical and public health research. It is expected that such master's level training will enhance the career development of individuals from developing countries, as well as strengthen and sustain the capacity to support ethical clinical and public health research at their home institutions and countries.

Recent Awards

View grant awards for the International Research Ethics Education And Curriculum Development Award (Bioethics)

Inquiries

Programmatic Issues

Barbara Sina, Ph.D.
Program Director
Division of International Training and Research
Fogarty International Center
National Institutes of Health
Building 31, Room B2C39
31 Center Drive, MSC 2220
Bethesda, MD 20892-2220
Telephone: (301) 402-9467
FAX: (301) 402-0779
Email: barbara_sina@nih.gov

Grants Management

Satabdi RaychowdhuryGrants Management Specialist
Fogarty International Center
Building 31, Room B2C29
31 Center Drive, MSC 2220
Bethesda, MD 20892-2220
Telephone: 301-496-9750
Fax: 301-594-1211
Email: Satabdi.Raychowdhury@nih.gov

NIH: Development of Novel Therapeutics for Select Anaerobic Protozoa (R21/R33)

NIH has announced a grant for the Development of Novel Therapeutics for Select Anaerobic Protozoa, an initiative that encourages the discovery, preclinical development and/or validation of novel interventions for the treatment of infectious diseases caused by select anaerobic protozoa (amebiasis, giardiasis, trichomoniasis and diseases caused by free-living amoebae).

Early stage translational and/or pre-clinical projects may include but are not limited to:

• Identification of drug targets and drug candidates, including (where appropriate) drug targets and drug candidates that are effective against the cyst form of a pathogen.
• Studies on the mechanism(s) of action and/or mechanism(s) of resistance that would promote the development of novel interventions.
• Identification of drug candidates with a superior profile to existing therapies (for example, potency, safety, efficacy against resistant strains, parasiticidal activity).
• Studies of novel formulations or drug combinations with a superior profile (as described above) to existing therapies.
• Identification of drug candidates with broad spectrum activity against anaerobic protozoa.
• Identification of mammalian host targets for the development of interventions.

The total project period for an application submitted in response to this FOA cannot exceed five years. Awards will support milestone-driven exploratory/feasibility “proof-of-concept” studies (two-year R21 phase), with possible rapid transition to expanded development (three-year R33 phase).

Key dates:

• Letter of intent due date: 30 September
• Application due date: 30 October
• Earliest project start date: July 2015

Funds:

• R21:
• 2 year project, direct costs up to USD 275,000 total, and maximum USD 200,000 direct costs in any single year
• R33:
• 3 year project, direct costs up to USD 300,000 total

To read the full RFA, please click here. If you are interested in applying to this grant, please contact Paul, Tim, or Glad at ORS.

NIH Call for Applications – International Research Scientist Development Award (IRSDA) (K01) – PAR-13-072

NIH has announced a call for applications for an International Research Scientist Development Award, which aims to develop young researchers’ careers by providing them with research experience in low- and middle-income countries (LMICs). This award is only for U.S. citizens who hold a research or health-professional doctoral degree and have at least two years of research experience beyond their doctoral degree. This is an opportunity to invite U.S. colleagues to conduct collaborative projects at FTM, as 50% of the grant period must be spent in LMICs, and they must have both U.S. and LMIC mentors.

The objective of this award is to prepare qualified individuals for research careers that will have a significant impact on the health-related research needs of low- and middle-income countries (LMICs) NIH invites K01 applications from biomedical, epidemiological, clinical, biostatistical, social and behavioral scientists in the formative stages of their research careers.

Program Overview

The International Research Scientist Development Award (IRSDA) provides support and protected time (three to five years) to advanced postdoctoral (at least two years beyond conferral of doctoral degree) U.S. research scientists for an intensive, mentored research career development experience leading to an independent research career focused on global health.

Funds:

NIH will contribute up to USD 75,000  per year towards the salary of the recipient, plus applicable fringe benefits.

NIH will contribute up to USD 30,000 per year toward research development costs of the recipient.

Key Dates:

• March 4, 2015
• Earliest start Date: December 2015
• Project duration: Maximum 5 years

If you have a U.S. colleague that you would like to conduct a collaborative project with, we urge you to contact them and start planning the application. Please be aware that the submitting institution would have to be the U.S. based one. If you are interested, or have further questions, please contact Paul, Tim, or Glad at ORS. 

Register as an Expert at Horizon 2020

Horizon 2020 is the largest EU funding initiative to date, with nearly 80 billion EUR available for researchers from any country working in any field over the next six years. There are regular calls for medical proposals, and this blog will stay updated with relevant opportunities for Faculty staff. To get a better insight into the Horizon 2020 funding process, and to build/expand your European professional network, we urge Faculty staff to sign up as Independent Experts for European Research and Innovation. Since Horizon 2020 grants typically require a European collaborator, this is a very easy and effective way to build your network and develop your insight into the world of European funding.

What do expert assignments involve?
Experts are essentially independent peer reviewers, and will be asked to assist with:

• Evaluation of proposals
• Monitoring of actions
• Assist with preparation, implementation, or evaluation of programmes and design of policies. 

Why should I register?
By registering as an expert, you may be invited to evaluate proposals from other researchers, giving you several benefits:

• Useful insights in the selection criteria of Horizon 2020 funding opportunities, improving your own chances of success
• Connecting you with other researchers around the world working in your field

Who can be an expert?
You can be selected as an expert if you:

• Have high-level expertise in a relevant field of research and innovation
• Are available for occasional, short-term assignments

How do I register as an expert?

Registering is easy – simply go to the Horizon 2020 Participant Portal, and click on the Work as an Expert icon, and follow the instructions. You will be asked to create an ECAS account, which you will use when you will submit a grant proposal to Horizon 2020 in the future, and to describe your areas of expertise.
To read more about Horizon 2020, or to see current funding opportunities, click on the link above. If you have any questions about Horizon 2020, or anything else related to international funding, please contact Paul, Tim, or Glad at the Office of Research Services.

NIH/NIAID Development of Novel Therapeutics for Select Anaerobic Protozoa (R21/R33)

Funding Opportunity Announcement (FOA) Number RFA-AI-14-015

Funding Opportunity Purpose 

The purpose of this FOA is to solicit applications to support early stage translational research focused on the development of novel therapeutics against select anaerobic protozoal pathogens.

Purpose/Research Objectives

Treatment of infectious diseases caused by anaerobic protozoal pathogens is compromised by limited effective therapeutic options and/or development of resistance. There is a critical need for development of new therapeutic approaches to treat these clinically-important diseases, including novel approaches such as small molecule antimicrobials and/or adjunctive therapeutics targeting resistance mechanisms. This initiative encourages the discovery, preclinical development and/or validation of novel interventions for the treatment of infectious diseases caused by select anaerobic protozoa (amebiasis, giardiasis, trichomoniasis and diseases caused by free-living amoebae).

Open Date (Earliest Submission Date) September 30, 2014

Letter of Intent Due Date September 30, 2014

Application Due Date October 30, 2014, by 5:00 PM local time of applicant organization

Earliest Start Date July 2015

Foreign Institutions Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.

Activity Code R21/R33 Phased Innovation Award

Award Budget

R21 Phase: 2 two years

Direct costs are limited to $275,000 over the 2 years; a maximum of $200,000 in direct costs is allowed in any single year.

R33 Phase: Direct costs are limited to $300,000 per year and cannot exceed 3 years. 

Consortia F&A (Indirect Costs/Overheads) are not included in the direct costs. 

The NIAID anticipates that a maximum of 50% of the funded R21 phase awards will progress to the R33 award.

Letter of Intent

Although a letter of intent is not required, is not binding, and does not enter into the review of a subsequent application, the information that it contains allows IC staff to estimate the potential review workload and plan the review.

By the date listed in Part 1. Overview Information, prospective applicants are asked to submit a letter of intent that includes the following information:

·         Descriptive title of proposed activity

·         Name(s), address(es), and telephone number(s) of the PD(s)/PI(s)

·         Names of other key personnel

·         Participating institution(s)

·         Number and title of this funding opportunity

The letter of intent should be sent to:

Annie Walker-Abbey, PhD
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 301-451-2671
Fax: 301-480-2408
Email: aabbey@niaid.nih.gov

If you want more information about the grant opportunity or need help with your application, please contact us at the Office of Research Services:

Paul: paul.ada@mahidol.ac.th  

Glad: gladgeorge.rot@mahidol.ac.th 

Tim: timothyjohn.col@mahidol.ac.th 

Tel; 023069125 or 023069126